Leukemia cutis

被引:225
作者
Cho-Vega, Jeong Hee [1 ,3 ]
Medeiros, L. Jeffrey [1 ]
Prieto, Victor G. [2 ]
Vega, Francisco [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Dermatopathol, Houston, TX 77030 USA
[3] Methodist Hosp, Dept Pathol, Houston, TX 77030 USA
关键词
leukemia cutis; histology; immunophenotype; molecular genetic pathogenesis;
D O I
10.1309/WYACYWF6NGM3WBRT
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Leukemia cutis (LC) is a nonspecific term used for cutaneous manifestations of any type of leukemia. LC has a wide range of cutaneous manifestations, which can make it difficult to clinically distinguish LC from other skin lesions. Patients with LC usually have concomitant systemic leukemia, but occasionally skin involvement precedes the involvement of the bone marrow or peripheral blood. Thus, a skin biopsy can be the first indication of the presence of leukemia in a subset of patients. The immunophenotyping of routinely processed skin biopsy specimens is very useful in establishing the diagnosis of LC Although the molecular mechanisms explaining the pathogenesis of LC are not well defined, chemokine receptors and adhesion molecules may have an important role in skin tropism. We review the literature and recent advances pertaining to LC, with special emphasis on the immunohistochemical assessment and possible mechanisms involved in skin tropism by leukemic cells.
引用
收藏
页码:130 / 142
页数:13
相关论文
共 83 条
[1]   A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis [J].
Agis, H ;
Weltermann, A ;
Fonatsch, C ;
Haas, O ;
Mitterbauer, G ;
Müllauer, L ;
Schreiber, S ;
Schwarzinger, I ;
Juretzka, W ;
Valent, P ;
Jäger, U ;
Lechner, K ;
Geissler, K .
ANNALS OF HEMATOLOGY, 2002, 81 (02) :90-95
[2]   Cutaneous findings in chronic lymphocytic leukaemia [J].
Agnew, KL ;
Ruchlemer, R ;
Catovsky, D ;
Matutes, E ;
Bunker, CB .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (06) :1129-1135
[3]   Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide a case report and review of the literature [J].
Alexandrescu, DT ;
Koulova, L ;
Wiernik, PH .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2005, 30 (04) :391-394
[4]   Leukaemia cutis in T-cell acute lymphoblastic leukaemia [J].
Ali, R .
CYTOPATHOLOGY, 2006, 17 (03) :158-161
[5]  
[Anonymous], 2001, WHO CLASSIFICATION T
[6]   Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma [J].
Avigdor, A ;
Raanani, P ;
Levi, I ;
Hardan, I ;
Ben-Bassat, I .
LEUKEMIA & LYMPHOMA, 2001, 42 (04) :683-+
[7]  
BAER MR, 1989, CANCER-AM CANCER SOC, V63, P2192, DOI 10.1002/1097-0142(19890601)63:11<2192::AID-CNCR2820631122>3.0.CO
[8]  
2-R
[9]   Expression of syndecan-1 is a sensitive marker for cutaneous plasmacytoma [J].
Bayer-Garner, IB ;
Joseph, L ;
Sanderson, RD ;
Smoller, BR .
JOURNAL OF CUTANEOUS PATHOLOGY, 2003, 30 (01) :18-22
[10]   Specific skin infiltration as first sign of chronic myelomonocytic leukemia with an unusual phenotype [J].
Braga, D ;
Manganoni, AM ;
Boccaletti, V ;
Pancera, C ;
Marocolo, D ;
Facchetti, F ;
DePanfilis, G .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (05) :804-807